Aequus Pharmaceuticals GAAP EPS of -$0.02, revenue of $1.38M

Stock Information for Aequus Pharmaceuticals Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Aequus Pharmaceuticals Inc

Aequus Provides Additional Disclosure in Connection with Annual General and Special Meeting of Shareholders
Aequus Announces Giovanni Di Genova Joining Board of Directors
Aequus Announces Sale of Zimed PF to Luvo Medical Technologies
Aequus Reports First Quarter 2025 Financial Highlights
Aequus Provides Update and Reports Third Quarter 2024 Financial Highlights.
Aequus Provides Update and Reports Third Quarter 2024 Financial Highlights
Aequus Reports Second Quarter 2024 Financial Highlights and General Update
Aequus Provides Launch Update Zimed PF

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.